arrow
W

Weifeng Xu

merck & company
H指数:18
被引数:3,766

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3) : a randomised, double-blind, active comparator controlled, international phase 3 trial
2024-10-013
PRE
A Phase 3 randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability and immunogenicity of a 21-valent PCV, V116, in pneumococcal vaccine-naive adults (STRIDE-3)

一项3期随机,双盲,主动比较对照研究,以评估21价PCV V116在未接种肺炎球菌疫苗的成年人 (STRIDE-3) 中的安全性,耐受性和免疫原性

2024-01-030
OAAI
Neutralizing Antibody Validation Testing and Reporting Harmonization
2023-07-0810
OA
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator- controlled, multicentre, US-based trial
2023-02-0137
PRE
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

基于麻疹载体的SARS-CoV-2候选疫苗V591在成人中的安全性和免疫原性: 1/2期随机,双盲,安慰剂对照,剂量范围试验的结果

2022-01-0121
OAAI
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen (vol 13, pg 170, 2012)
2014-01-211
OAAI
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
2011-12-25644
OAAI